A new study published in BMJ Sexual and Reproductive Health has revealed a notable increase in the number of women seeking abortions despite using 'natural' contraceptive methods such as fertility tracking applications.

Conducted in England and Wales, the research indicates a significant shift over the past five years from traditional hormonal contraceptives, like the pill, to fertility awareness-based methods.

Researchers from the University of Edinburgh analyzed data collected by the British Pregnancy Advisory Service, comparing periods from January to June 2018 and the same months in 2023. Findings show a decrease in the use of hormonal contraceptives, which dropped from 19% to 11%, and a rise in natural method usage, albeit still a minority, which increased from 0.4% to 2.5%.

The growing adoption of these methods calls for further investigation, experts suggest.

Fertility tracking apps aim to identify the days a woman is most fertile based on her menstrual cycle.

These apps often rely on metrics such as basal body temperature to predict ovulation.

While companies claim these tools can be up to 93% reliable when used correctly, the National Health Service (NHS) warns that without strict adherence to usage guidelines, their effectiveness drops dramatically, resulting in a significant risk of unintended pregnancy.

Comparative data on traditional contraceptives shows the pill and mini pill provide 91% effective 'typical use' rates and 99% effectiveness with 'perfect use,' whereas hormonal coils or implants offer a constant 99% success rate, independent of user compliance.

Dr. Rosie McNee, a lead researcher in the study, points to the recent surge in eHealth, including fertility apps and period trackers, as an area requiring careful scrutiny.

The proliferation of such technologies, some less reliable than others, does not require prescriptions, potentially leading to gaps in crucial user information.

Tanya Lane from MSI Reproductive Choices UK echoes these findings, noting a concurrent increase in women opting for fertility awareness methods.

She attributes part of this trend to the influence of social media platforms, where individuals share personal experiences and advocate for these methods.

Long wait times for appointments at GP surgeries and sexual health clinics may also be influencing the trend as convenient access to long-acting contraceptives continues to pose a challenge in various parts of the UK.

Paula Baraitser, medical director at SH:24, partnered with the NHS, underscores the need for an expanded range of contraceptive choices.

Over a lifespan of potential contraceptive use, which may extend over 30 years, individual experiences with hormonal contraception can vary dramatically.

This variability underscores the necessity for investment in innovative contraception research, a sector that has seen limited advancement over the past half-century.

In light of these developments, healthcare professionals stress the importance of informed decision-making and counsel for women considering switching to fertility tracking methods.

The inclusion of discussions regarding the broader benefits of hormonal contraceptives, such as managing menstrual health, remains crucial.

The study's authors suggest addressing misconceptions through educational initiatives, ensuring women are fully aware of their contraceptive choices and associated risks.